Clinical & Experimental Metastasis

Papers
(The median citation count of Clinical & Experimental Metastasis is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
The value of case reports in rare oncological scenarios: mixed method analysis of colorectal metastases from breast cancer83
Congratulations to Prof. em. Garth L. Nicolson – co-founder of Clinical & Experimental Metastasis67
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancer61
Intraperitoneal drug delivery systems releasing cytostatic agents to target gastro‐intestinal peritoneal metastases in laboratory animals: a systematic review45
Stereotactic body radiation therapy for adrenal gland metastases: outcome and predictive factors from a multicenter analysis42
The gastrointestinal microbiota in colorectal cancer cell migration and invasion40
Cutting-edge innovations in breast cancer diagnosis- the potential of HDMI biomarkers33
Metastatic profiling of HER2-positive breast cancer cell lines in xenograft models33
Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics33
Portal vein tumor thrombosis in hepatocellular carcinoma: molecular mechanism and therapy31
Efficacy and safety of thoracic radiotherapy for extensive stage small cell lung cancer after immunotherapy in real world30
The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic study30
Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics29
Current status of gastrointestinal tract cancer brain metastasis and the use of blood-based cancer biomarker biopsy25
Cancer heterogeneity and metastasis: life at the edge22
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275)19
Donald L. Morton Memorial Lecture: the legacy of Donald Morton: past, present and future19
Detection of sentinel lymph nodes by tilmanocept in oral squamous cell carcinoma18
The effect of the low stromal ratio induced by neoadjuvant chemotherapy on recurrence patterns in borderline resectable pancreatic ductal adenocarcinoma18
A new Neu—a syngeneic model of spontaneously metastatic HER2-positive breast cancer16
Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches15
The movement of mitochondria in breast cancer: internal motility and intercellular transfer of mitochondria15
Pulmonary lysyl oxidase expression and its role in seeding Lewis lung carcinoma cells15
Factors associated with the distribution of brain metastases in lung cancer: a retrospective study15
LITAF inhibits colorectal cancer stemness and metastatic behavior by regulating FOXO1-mediated SIRT1 expression14
Immunotherapy of cancer in the era of checkpoint inhibitor14
PIM3 kinase promotes tumor metastasis in hepatoblastoma by upregulating cell surface expression of chemokine receptor cxcr414
Development and characterization of a rat brain metastatic tumor model by multiparametric magnetic resonance imaging and histomorphology14
Nanoparticles loaded with circ_0086375 for suppressing the tumorigenesis of pancreatic cancer by targeting the miR-646/SLC4A4 axis14
Prostate cancer addiction to oxidative stress defines sensitivity to anti-tumor neutrophils14
Emerging photoacoustic and thermoacoustic imaging technologies for detecting primary and metastatic cancer and guiding therapy14
CXCL2-CXCR2 axis mediates αV integrin-dependent peritoneal metastasis of colon cancer cells13
Targeting CD44 and other pleiotropic co-receptors as a means for broad inhibition of tumor growth and metastasis13
Poor patient outcome correlates with active engulfment of cytokeratin positive CTCs within cancer-associated monocyte population in lung cancer13
Microarray-based detection and expression analysis of drug resistance in an animal model of peritoneal metastasis from colon cancer13
PET/CT in assessment of colorectal liver metastases: a comprehensive review with emphasis on 18F-FDG13
Multi-marker analysis of circulating tumor cells in localized intermediate/high-risk and metastatic prostate cancer13
Molecular and cellular mechanisms controlling integrin-mediated cell adhesion and tumor progression in ovarian cancer metastasis: a review12
Cancer neoantigens as potential targets for immunotherapy12
Secondary lymphedema from cancer therapy12
Occludin is overexpressed in tubo-ovarian high-grade serous carcinoma compared to mesothelioma and is a marker of tumor progression and chemoresistance11
EGFL6 promotes bone metastasis of lung adenocarcinoma by increasing cancer cell malignancy and bone resorption11
Detection of melanoma, breast cancer and head and neck squamous cell cancer sentinel lymph nodes by Tc-99m Tilmanocept (Lymphoseek®)11
Correction: Predictive value of 18 F-FDG PET/CT versus bone marrow biopsy and aspiration in pediatric neuroblastoma10
In-transit metastatic cutaneous melanoma: current management and future directions10
Molecular mechanisms of cancer metastasis via the lymphatic versus the blood vessels10
The lymphatic system and sentinel lymph nodes: conduit for cancer metastasis10
Predictive value of 18 F-FDG PET/CT versus bone marrow biopsy and aspiration in pediatric neuroblastoma10
Stereotactic radiotherapy for liver oligometastases: a pooled analysis following the estro/eortc consensus recommendations10
Breast cancer disparities in outcomes; unmasking biological determinants associated with racial and genetic diversity9
Application of CTC discoveries for liquid biopsy: the RPL/RPS gene signature of melanoma CTCs is linked to brain metastasis onset9
Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics8
Clinical applications of circulating tumor cells in patients with solid tumors8
Oncolytic intralesional therapy for metastatic melanoma8
Letter: Estimating the baseline local recurrence rate for a brain metastasis after neurosurgical resection8
Beta-blocker adjunct therapy as a prospective anti-metastatic with cardio-oncologic regulation8
Lung-derived soluble factors support stemness/plasticity and metastatic behaviour of breast cancer cells via the FGF2-DACH1 axis8
Should EUS-FNA be considered also for the diagnosis of peripheral small pulmonary lesions?8
Acetone compression improves lymph node yield and metastasis detection in colorectal cancer8
Preoperative embolization of renal cell carcinoma metastases to the bone prior to stabilization procedures does not result in reduction in intraoperative blood loss8
Molecular prognostic indicators in HPV-positive oropharyngeal cancer: an updated review7
Endobronchial ultrasound-guided transbronchial needle aspiration in peripheral pulmonary lesions: a systematic review and meta-analysis7
Innovations in radiotherapy and advances in immunotherapy for the treatment of brain metastases7
Lymph nodes in oral squamous cell carcinoma: a comprehensive anatomical perspective7
Current pharmacologic treatment of brain metastasis in non-small cell lung cancer7
Stereotactic body radiotherapy for spinal oligometastases: a survey on patterns of practice on behalf of the Italian Association of Clinical Oncology and Radiotherapy (AIRO)7
Introduction: Novel Frontiers in Cancer Metastasis7
Stereotactic body radiotherapy to lymph nodes in oligoprogressive castration-resistant prostate cancer patients: a post hoc analysis from two phase I clinical trials7
Interrogating the roles of lymph node metastasis in systemic immune surveillance7
Correction to: Editorial: Cancer metastasis through the lymphovascular system: molecular mechanisms of cancer metastasis7
The role of host response to chemotherapy: resistance, metastasis and clinical implications7
Long non-coding RNA NRSN2-AS1, transcribed by SOX2, promotes progression of esophageal squamous cell carcinoma by regulating the ubiquitin-degradation of PGK17
Serum conversion pattern of SCC-Ag levels between pre- and post-chemoradiotherapy predicts recurrence and metastasis in cervical cancer: a multi-institutional analysis6
Bringing precision oncology to cellular resolution with single-cell genomics6
Neoadjuvant therapy for resectable melanoma6
Novel approach involving stereotactic body radiotherapy followed by intramedullary nail placement for long bone metastases: a case report6
Cancer metastasis through the lymphatic versus blood vessels6
The smac mimetic LCL161 targets established pulmonary osteosarcoma metastases in mice6
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results6
Role of CD44 isoforms in epithelial-mesenchymal plasticity and metastasis6
High sensitivity flow cytometry immunophenotyping increases the diagnostic yield of malignant pleural effusions5
Establishing patient-derived tumor organoids of bone metastasis from lung adenocarcinoma reveals the transcriptomic changes underlying denosumab treatment5
Axillary nodal staging in breast cancer: what have we learned?5
PD-L1 and VEGF dual blockade enhances anti-tumor effect on brain metastasis in hematogenous metastasis model5
Circulating tumour cells are associated with histopathological growth patterns of colorectal cancer liver metastases5
Characterizing perfusion defects in metastatic lymph nodes at an early stage using high-frequency ultrasound and micro-CT imaging5
Ketogenic diet does not promote triple-negative and luminal mammary tumor growth and metastasis in experimental mice5
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy 5
Targeting PADI2 as a potential therapeutic strategy against metastasis in oral cancer via suppressing EMT-mediated migration and invasion and CCL3/5-induced angiogenesis5
Pembrolizumab in patients with advanced upper tract urothelial carcinoma: a real-world study from ARON-2 project5
‘Sandwich treatment’ for posterior fossa brain metastases with volume larger than 4cm3: a multicentric retrospective study5
Correction to: Assessment of incentivizing effects for cancer care frameworks5
Data mining of key genes expression in hepatocellular carcinoma: novel potential biomarkers of diagnosis prognosis or progression4
Treating colorectal peritoneal metastases with an injectable cytostatic loaded supramolecular hydrogel in a rodent animal model4
Correction to: PITX1 suppresses osteosarcoma metastasis through exosomal LINC00662-mediated M2 macrophage polarization4
New perspectives in unresectable cholangiocarcinoma? Evaluation of chemosaturation with percutaneous hepatic perfusion as a palliative treatment option4
Stereotactic body radiotherapy (SBRT) and concomitant systemic therapy in oligoprogressive breast cancer patients4
Mapping the single cell spatial immune landscapes of the melanoma microenvironment4
Establishment and Image based evaluation of a New Preclinical Rat Model of Osteoblastic Bone Metastases4
Current challenges in metastasis research and future innovation for clinical translation3
Molecular mechanisms of sensitivity and resistance to radiotherapy3
Cardiooncology—dealing with modern drug treatment, long-term complications, and cancer survivorship3
CD276 promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma through the TGF-β/SMAD signaling3
Forty years on: a brief history of clinical and experimental metastasis3
Risk factors for surgical site infection and association of surgical site infection with survival of lower rectal cancer patients without clinical lateral pelvic lymph node metastasis (clinical Stage 3
PITX1 suppresses osteosarcoma metastasis through exosomal LINC00662-mediated M2 macrophage polarization3
Cell blebbing novel therapeutic possibilities to counter metastasis3
Mechanisms of breast cancer metastasis3
SBRT for elderly oligometastatic patients as a feasible, safe and effective treatment opportunity3
How much do we know about the metastatic process?3
Platycodin D represses β-catenin to suppress metastasis of cetuximab-treated KRAS wild-type colorectal cancer cells3
ADC textural features in patients with single brain metastases improve clinical risk models3
PD-L1 blockade exhibits anti-tumor effect on brain metastasis by activating CD8+ T cells in hematogenous metastasis model with lymphocyte infusion3
Cancer microenvironment and genomics: evolution in process3
Comparison of trastuzumab emtansine, trastuzumab deruxtecan, and disitamab vedotin in a multiresistant HER2-positive breast cancer lung metastasis model3
Inhibition of LPS-mediated TLR4 activation abrogates gastric adenocarcinoma-associated peritoneal metastasis3
Brain metastases from hepatopancreatobiliary malignancies3
Histopathological growth patterns of resected non-colorectal, non-neuroendocrine liver metastases: a retrospective multicenter study3
Collective metastasis: coordinating the multicellular voyage3
Editorial: Novel Frontiers in Cancer Metastasis3
Cancer cell metabolic plasticity in migration and metastasis3
0.093515872955322